Loading clinical trials...
Loading clinical trials...
Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1(GLP-1) Receptor Agonists
The purpose of this study is to determine the type of gastric content and quantify the volume of liquid gastric contents using ultrasonography in patients on GLP-1 agonists that have presented for elective surgery and to determine if risk factors are associated with a higher gastric volume in patients on GLP-1 receptor agonists.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Start Date
June 6, 2023
Primary Completion Date
July 12, 2023
Completion Date
July 12, 2023
Last Updated
August 2, 2023
132
ACTUAL participants
Gastric ultrasound
DIAGNOSTIC_TEST
Lead Sponsor
The University of Texas Health Science Center, Houston
NCT07100691
NCT05519969
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06303492